July 21, 2020, 03.04 PM

WASHINGTON, KOMPAS.com – American conglomerate Johnson & Johnson is in the midst of several negotiations with various countries for its potential Covid-19 vaccine.

The company is preparing to start human trials for its vaccine, according to Chief Financial Officer Joseph Wolk during an interview with Reuters.

The Japanese government and the Bill and Melinda Gates Foundation are among some of the parties engaged with Johnson & Johnson about locking up allocation for the company’s potential Covid-19 vaccine.

Read also: China's Covid-19 Vaccine Brought to Indonesia for Phase 3 Clinical Trials

Reuters previously reported that the European Union is also in talks with the American conglomerate.

Around the world, drugmakers are working to increase the supply for their vaccines in the face of unprecedented demand.

There have been more than 100 Covid-19 vaccines under development to stop the deadly virus.

Read also: Western Governments Accuse Russia of Hacking Virus Vaccine Trials

Johnson & Johnson has already made an agreement with the United States government to prioritize vaccine allocation for the world’s largest economy.

The move is part of the company’s funding agreement with the US government's Biomedical Advanced Research and Development Authority (BARDA), Joseph Wolk noted.

Page:


Latest Video Video Lainnya >

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
November 28, 2022, 05.16 PM

Death Toll from Indonesia Quake Rises to 321

News
November 24, 2022, 05.14 PM

Malaysia: Opposition Leader Anwar Ibrahim Named PM

News
November 18, 2022, 10.31 PM

Indonesia Reports over 6,600 Daily Covid-19 Cases

News
November 18, 2022, 09.57 PM

6.9-Magnitude Quake Strikes Off Western Indonesia

Close Ads